23.01.2018 | Biesterfeld Spezialchemie GmbH
Biesterfeld and Grillo sign agreement on distribution of zinc oxide for the pharmaceutical industry
Biesterfeld Spezialchemie has assumed the distribution of pharmaceutical zinc oxides produced by the German manufacturer Grillo Zinkoxid GmbH with immediate effect. With the cooperation agreements covering Poland, Spain, Italy, the UK, France and the German-speaking area, the distributor is augmenting its portfolio of excipients and active ingredients for the pharmaceutical industry.
The zinc oxides, Pharma 4 GMP, Pharma 6 GMP and Pharma 8 GMP, are pharmaceutically pure zinc oxides, produced from highly pure metallic SHG zinc in accordance with the EU GMP guidelines and complying with the purity standards of the pharmacopoeias (Ph. Eur., BP and USP) currently in effect.
The zinc oxides are used in human and veterinary medicine. Because of their anti-inflammatory and antiseptic properties they are ideal for use in the treatment of wounds, inflammations and skin conditions, such as intertrigo. As a mineral UV absorber, the zinc oxide used in sunscreen products protects against UV-A radiation.
"We are very pleased to sign the cooperation agreement with Grillo Zinkoxid," says Dr Andreas Lekebusch, Business Manager Healthcare at Biesterfeld Spezialchemie. "As a traditional and family-run company, Grillo offers customer-focused solutions for the use of zinc oxides. The products are ideally suited for providing end-to-end service for customers focusing on areas of treatment such as skin and wounds. With its high quality standards, Grillo is a perfect match for Biesterfeld."
A family-owned company that has had its headquarters in Duisburg since its foundation in 1842, Grillo is one of the market leaders in Europe for the processing of zinc and sulphur. Today, the group is structured into the Chemicals, Zinc Oxide, Metal and RHEINZINK® divisions with a headcount of around 1,600 employees handling its worldwide operations. Zinc oxides of various qualities are developed and manufactured at the Grillo Zinkoxid GmbH facility in Goslar. The wide range of ways in which zinc oxide can be used in many different market segments requires a high level of innovation and customer focus.
True to their motto "Progress as a tradition", the development of new processes, procedures, materials and chemicals in all business divisions has been a core focus since the founding of the company, with the aim of optimising the products. In this regard the Research and Development departments are staffed by highly qualified specialists tasked with handling the various projects.
Registration number pharmaceutical zinc oxides: DE_NI_Reg_2017_0001
Contact product portfolio Grillo:
20095 Hamburg, Germany
Phone: +49 40 32008-252